EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Role of Hyaluronan and Its Membrane Receptors, CD44 and RHAMM, in Obesity-Related Kidney Pathology

Bingxue Qi, Vishal Musale, Xiong Weng iD, Ayman K Banah iD, Alexander Lawlor, Colin E Murdoch iD, Abigail C Lay iD, Kate J Heesom iD, Richard J M Coward iD, Christopher L O'Connor, Wenjun Ju, Markus Bitzer iD und 3 weitere

Biomolecules · 14.11.2025 · 15 (11) · 1598

DOI: 10.3390/biom15111598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 14.11.2025. Verfasst von Bingxue Qi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Endocrinology and Reproductive Biology, School of Medicine, University of Dundee, Dundee DD1 9SY, UK. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Hyaluronic Acid, Obesity, Extracellular Matrix Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes UK, British Heart Foundation, Natural Science Foundation of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity-related kidney pathology (ORKP) is a major global issue that contributes to diabetic nephropathy and kidney cancer and leads to chronic/end-stage kidney disease. Current treatments for ORKP are limited because of the incomplete understanding of the disease pathogenesis. Here, we identified a novel role for hyaluronan (HA) and its membrane receptors, CD44 and RHAMM, in this condition. Obesity-induced increases in HA deposition and CD44 and RHAMM expression are detrimental to the kidney via activation of the TGF-β1/Smad2/3, P38/JNK MAPK, and ROCK/ERK pathways, leading to glomerulopathy, tubular injury, inflammation, albuminuria, and elevated serum creatinine concentrations. Either pharmacological or genetic ablation of HA, CD44, or RHAMM reverses these obesity-driven pathologies in vivo. We further established a mechanistic link between renal insulin resistance and ECM remodelling using human kidney cells in vitro, providing insight into the cell type-specific role of HA, CD44, and RHAMM in the pathogenesis of ORKP. Finally, analysis of glomerular and tubular fractions of human kidney biopsy samples revealed increased expression of CD44 and RHAMM in chronic kidney disease and diabetic nephropathy, and their expression correlated with markers of kidney dysfunction. Our findings provide evidence for HA-CD44/RHAMM as a potential therapeutic target in ORKP and subsequent prevention of chronic kidney disease. While previous studies have implicated CD44 and RHAMM in renal disease and fibrosis, our work for the first time provides an integrated analysis of both receptors in the context of ORKP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsHyaluronic AcidObesityExtracellular Matrix ProteinsKidneyKidney DiseasesHumansAnimalsMiceMaleMice, Inbred C57BLDiabetic Nephropathies

Stichwörter der Autor:innen

CD44RHAMMhyaluronaninsulin resistancekidneymiceobesity

Substanzen

Hyaluronan ReceptorsHyaluronic AcidExtracellular Matrix Proteinshyaluronan-mediated motility receptorCD44 protein, human

Autor:innen und Institutionen

  • Division of Diabetes, Endocrinology and Reproductive Biology, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.
  • Precision Molecular Medicine Center, Jilin Province People's Hospital, Changchun 130021, China.
  • Division of Cardiovascular Research, School of Medicine, University of Dundee, Dundee DD1 4HN, UK.
  • Division of Cardiovascular Sciences, University of Manchester, Manchester M13 9PL, UK.
  • Bristol Renal, Bristol Medical School, University of Bristol, Bristol BS8 1QU, UK.
  • Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

ORCID-Profile: Xiong Weng, Ayman K Banah, Colin E Murdoch, Abigail C Lay, Kate J Heesom, Richard J M Coward, Markus Bitzer, Li Kang

Förderung

  • Diabetes UK
  • British Heart Foundation
  • Natural Science Foundation of Jilin Province
  • Innovative Medicines Initiative 2 Joint Undertaking (JU)
  • Medical Research Council
  • Kidney Research UK Intermediate Fellowship
  • British Heart Foundation Manchester Research Excellence Award
  • British Heart Foundation Manchester Accelerator Award

Zitieren

APA

Qi, B., Musale, V., Weng, X., Banah, A. K., Lawlor, A., Murdoch, C. E., Lay, A. C., Heesom, K. J., Coward, R. J. M., O'Connor, C. L., Ju, W., Bitzer, M., Hills, C. E., Chen, Y., & Kang, L. (2025). A Novel Role of Hyaluronan and Its Membrane Receptors, CD44 and RHAMM, in Obesity-Related Kidney Pathology. Biomolecules, 15(11), 1598. https://doi.org/10.3390/biom15111598

Vancouver

Qi B, Musale V, Weng X, Banah AK, Lawlor A, Murdoch CE, et al. A Novel Role of Hyaluronan and Its Membrane Receptors, CD44 and RHAMM, in Obesity-Related Kidney Pathology. Biomolecules. 2025;15(11):1598. doi:10.3390/biom15111598

BibTeX
@article{Qi2025,
  author = {Qi, Bingxue and Musale, Vishal and Weng, Xiong and Banah, Ayman K and Lawlor, Alexander and Murdoch, Colin E and Lay, Abigail C and Heesom, Kate J and Coward, Richard J M and O'Connor, Christopher L and Ju, Wenjun and Bitzer, Markus and Hills, Claire E and Chen, Yang and Kang, Li},
  title = {A Novel Role of Hyaluronan and Its Membrane Receptors, CD44 and RHAMM, in Obesity-Related Kidney Pathology},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {1598},
  doi = {10.3390/biom15111598}
}
Kostenlos starten →